Inner Mongolia Duhe Innovation R & D Tech Co., Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jun 2044
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 21, 2027.
Recent changes
- 2 of the patents on this record were granted since Aug 23, 2026
- Sep 15 US 12,735,384 Methods for Preparing (2S,3R,4R)-4,5-Dihydroxyisoleucine Derivative and Intermediates Thereof
- Sep 1 US 12,723,060 Preparation Method, Intermediates, and Use of Cyclic Peptide Toxin Alpha-Amanitin And/Or Amaninamide
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 2 of 2
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,723,060 | Preparation Method, Intermediates, and Use of Cyclic Peptide Toxin Alpha-Amanitin And/Or Amaninamide In force · High confidence | In force | High confidence | |
| US 12,735,384 | Methods for Preparing (2S,3R,4R)-4,5-Dihydroxyisoleucine Derivative and Intermediates Thereof In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.